​

Ardent Health Partners (ARDT) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChart

ARDT Stock Forecast

Ardent Health Partners (ARDT) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $23.00, with a high of $27.00 and a low of $20.00. This represents a 56.46% increase from the last price of $14.70.

$10 $14 $18 $22 $26 $30 High: $27 Avg: $23 Low: $20 Last Closed Price: $14.7

ARDT Stock Rating

Ardent Health Partners stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

ARDT Forecast vs Benchmarks

TypeNameUpside
StockArdent Health Partners56.46%
SectorHealthcare Stocks 25.20%
IndustryMedical Care Facilities Stocks19.03%

Price Target Trends

1M3M12M
# Anlaysts--7
Avg Price Target--$22.71
Last Closing Price$14.70$14.70$14.70
Upside/Downside--54.49%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25262--10
Dec, 24262--10
Nov, 24472--13
Oct, 24471--12
Sep, 24471--12
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 10, 2024Matthew GillmorKeyBanc$24.00$18.1232.45%63.27%
Sep 19, 2024Scott FidelStephens$24.00$17.2139.45%63.27%
Aug 16, 2024Timothy GreavesLoop Capital Markets$21.00$16.9723.75%42.86%
Aug 16, 2024David MacDonaldTruist Financial$22.00$16.9729.64%49.66%
Aug 12, 2024David MacDonaldTruist Financial$21.00$15.6434.27%42.86%
Aug 12, 2024Ann HynesMizuho Securities$20.00$15.6427.88%36.05%
Aug 12, 2024Craig HettenbachMorgan Stanley$27.00$15.6472.63%83.67%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 06, 2024Bank of America SecuritiesNeutraldowngrade
Oct 10, 2024KeyBancOverweightinitialise
Sep 19, 2024StephensOverweightOverweighthold
Aug 16, 2024Loop Capital MarketsBuyBuyhold
Aug 12, 2024CitigroupBuyinitialise
Aug 12, 2024RBC CapitalOutperforminitialise
Aug 12, 2024Morgan StanleyOverweightinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$0.38----
Avg Forecast$0.18$1.22$1.99$2.19$2.38
High Forecast$0.18$1.06$1.84$2.05$2.25
Low Forecast$0.18$1.31$2.14$2.46$2.51
Surprise %111.11%----

Revenue Forecast

$5B $6B $6B $7B $7B $8B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$5.41B----
Avg Forecast$5.63B$5.85B$6.32B$6.68B$7.09B
High Forecast$5.59B$5.84B$6.29B$6.60B$7.00B
Low Forecast$5.66B$5.86B$6.36B$6.74B$7.15B
Surprise %-3.98%----

Net Income Forecast

$0 $80M $160M $240M $320M $400M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$50.29M----
Avg Forecast$25.47M$169.77M$277.05M$314.47M$340.30M
High Forecast$25.26M$151.86M$263.60M$293.69M$322.34M
Low Forecast$25.68M$187.67M$306.58M$352.43M$359.59M
Surprise %97.47%----

ARDT Forecast FAQ

Is Ardent Health Partners stock a buy?

Ardent Health Partners stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Ardent Health Partners is a favorable investment for most analysts.

What is Ardent Health Partners's price target?

Ardent Health Partners's price target, set by 7 Wall Street analysts, averages $23 over the next 12 months. The price target range spans from $20 at the low end to $27 at the high end, suggesting a potential 56.46% change from the previous close price of $14.7.

How does Ardent Health Partners stock forecast compare to the average forecast of its sector, industry, and investment themes?

Ardent Health Partners stock forecast shows a 56.46% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the medical care facilities stocks industry (19.03%).

What is the breakdown of analyst ratings for Ardent Health Partners over the past three months?

  • January 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 30.77% Strong Buy, 53.85% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.

What is Ardent Health Partners’s EPS forecast?

Ardent Health Partners's average annual EPS forecast for its fiscal year ending in December is 1.22 for 2024, a 221.05% increase from the reported $0.38 in 2023. The prediction for 2025 is $1.99, $2.19 for 2026, and $2.38 for 2027.

What is Ardent Health Partners’s revenue forecast?

Ardent Health Partners's average annual revenue forecast for its fiscal year ending in December is $5.85B for 2024, a 8.14% increase from the reported $5.41B in 2023. The forecast for 2025 is $6.32B, $6.68B for 2026, and $7.09B for 2027.

What is Ardent Health Partners’s net income forecast?

For its fiscal year ending in December, Ardent Health Partners's average annual net income forecast is $169.77M for 2024, reflecting an 237.56% increase from the reported $50.29M in 2023. The projection for 2025 is $277.05M, $314.47M for 2026, and $340.3M for 2027.